Hints and tips:
Related Special Reports
Related Topics
...Pharma groups and biotechs can be locked into contracts with WuXi for up to five years into the future, said Crowley....
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
...Still, total returns on units in Axa Framlington’s biotech fund have risen close to 10 per cent over three years and Polar Capital’s biotech fund is up nearer 20 per cent compared with the S&P Biotech index...
...Specification: Biopsychology Click the link below to read the and then answer the questions: UK biotech group raises £48mn for Alzheimer’s research The article notes that “neurons are the fundamental...
...German pharma group Boehringer Ingelheim has struck an up to $1bn partnership with a UK biotech to develop treatments for chronic liver disease that aim to harness the organ’s capacity to regenerate....
...A total of nine biotechs have gone public on US markets this quarter, raising $1.4bn between them....
...[MUSIC PLAYING] American biotech companies are rushing to raise funds on US stock markets at the fastest rate since the biotech boom of the pandemic....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Mentioned in this podcast: US biotech fundraising boom ends 2-year deal drought Is the EU’s Covid recovery fund failing?...
...Chinese biotech companies fell, with WuXi Biologics retreating 21 per cent, WuXi AppTec dropping 18 per cent and Pharmaron down 15 per cent....
...A new biotech company that aims to harness the immune system to treat a range of skin diseases will launch on Monday with $100mn in seed financing....
...“Both biotech and non-biotech IPOs benefit from a lot of the same underlying economic circumstances . . ....
...Europe needs to learn from US shareholders willing to make big bets on biotech if it wants to create a thriving homegrown industry, according to the chief executive of Argenx, one of the bloc’s largest biotech...
...US lawmakers have put the sector under scrutiny in relations with China and are seeking to restrict companies with federal funding from contracting with “foreign adversary” biotech groups of “concern” deemed...
...The agreement also prompted the US biotech company to remove a “going concern” notice that was issued a year ago and had put pressure on the stock....
...The investor interest in businesses developing psychedelics comes as the broader biotech sector enjoys a revival....
...A rally in biotech stocks has raised hopes of a turnaround from the sector’s worst run this century, as drug developers suffered from rising interest rates and a backlash to pandemic-era euphoria....
...Biotech stocks carry high risks that products under development will fail. Chinese biotechs now come with an added ingredient: political risk....
...A long-awaited approval decision on Moderna’s second commercial product after its Covid-19 jab has been delayed by several weeks, the US biotech said on Friday....
...The Hang Seng Hong Kong-Listed Biotech index has declined more than 7 per cent this week....
...The real pain was concentrated among pure-play biotechs that were overhyped on trial progress as they rapidly ran out of money....
...Novo Nordisk has signed deals worth up to $1bn with US biotech start-ups developing treatments for obesity and other cardiometabolic diseases, as the Wegovy manufacturer seeks to stay ahead in a major new...
...These techniques — the “holy grail of biotech” — allow genetic improvements to be made remotely with “the ease of a software update”....
...It says it needs improved access to capital, but it claims to be one of the largest biotech fundraisers in recent years....
...A new venture, led by the founder of a biotech group that was sold to Sanofi for up to $1.45bn in 2021, has won £48mn in funding for research into cancer treatments using machine learning and genetically...
International Edition